Detect announced today that it received FDA emergency use authorization (EUA) to sell its COVID-19 test over the counter. Guilford, Connecticut-based Detect develops a molecular rapid test designed to identify SARS-CoV-2, the virus causing COVID-19, at lower viral loads than antigen tests to allow for earlier detection, according to a news release. The Detect COVID-19 […]